STOCK TITAN

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Cerus (Nasdaq: CERS) has scheduled the release of its fourth quarter and full-year 2024 financial results for Thursday, February 20, 2025, after market close. The company will host a conference call and webcast at 4:30 P.M. ET on the same day, featuring management discussions on financial results, business overview, and outlook.

Interested participants can access the webcast and presentation slides through Cerus' Investor Relations webpage at http://ir.cerus.com. While early joining is encouraged (10 minutes prior), it's not mandatory. A replay of the event will be available on the company's website approximately three hours after the call until March 6, 2025.

Cerus (Nasdaq: CERS) ha programmato la pubblicazione dei suoi risultati finanziari del quarto trimestre e dell’anno intero 2024 per giovedì 20 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET nello stesso giorno, con discussioni da parte della direzione sui risultati finanziari, una panoramica dell'azienda e le prospettive future.

I partecipanti interessati possono accedere al webcast e alle diapositive della presentazione tramite la pagina Web delle Relazioni con gli Investitori di Cerus all'indirizzo http://ir.cerus.com. Anche se è consigliato unirsi in anticipo (10 minuti prima), non è obbligatorio. Una registrazione dell'evento sarà disponibile sul sito dell'azienda circa tre ore dopo la chiamata fino al 6 marzo 2025.

Cerus (Nasdaq: CERS) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 20 de febrero de 2025, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica y un webcast a las 4:30 P.M. ET el mismo día, con discusiones de los directivos sobre los resultados financieros, la visión general del negocio y las perspectivas.

Los participantes interesados pueden acceder al webcast y a las diapositivas de la presentación a través de la página de Relaciones con Inversores de Cerus en http://ir.cerus.com. Se recomienda unirse temprano (10 minutos antes), aunque no es obligatorio. Una grabación del evento estará disponible en el sitio web de la empresa aproximadamente tres horas después de la llamada hasta el 6 de marzo de 2025.

세루스 (Nasdaq: CERS)는 2025년 2월 20일 목요일 시장 마감 후 2024년 4분기 및 연간 재무 결과 발표를 예정했습니다. 회사는 같은 날 오후 4시 30분 ET에 경영진이 재무 결과, 사업 개요 및 전망에 대해 논의하는 전화 회의 및 웹캐스트를 개최할 것입니다.

관심 있는 참가자는 http://ir.cerus.com에서 세루스의 투자자 관계 웹 페이지를 통해 웹캐스트 및 프레젠테이션 슬라이드에 접근할 수 있습니다. 일찍 참여하는 것이 권장되지만 (10분 전), 의무는 아닙니다. 이벤트의 재생은 통화 후 약 3시간 후, 2025년 3월 6일까지 회사 웹사이트에서 제공될 것입니다.

Cerus (Nasdaq: CERS) a programmé la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le jeudi 20 février 2025, après la fermeture du marché. L'entreprise tiendra une téléconférence et un webcast le même jour à 16h30 ET, avec des discussions de la direction sur les résultats financiers, un aperçu de l'entreprise et les perspectives.

Les participants intéressés peuvent accéder au webcast et aux diapositives de présentation via la page des relations investisseurs de Cerus à l'adresse http://ir.cerus.com. Bien qu'il soit conseillé de se joindre en avance (10 minutes avant), ce n'est pas obligatoire. Un enregistrement de l'événement sera disponible sur le site de l'entreprise environ trois heures après l'appel jusqu'au 6 mars 2025.

Cerus (Nasdaq: CERS) hat die Veröffentlichung ihrer Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf Donnerstag, den 20. Februar 2025, nach Marktschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast abhalten, in dem die Geschäftsführung über die Finanzergebnisse, den Unternehmensüberblick und die Aussichten diskutiert.

Interessierte Teilnehmer können über die Investor Relations-Webseite von Cerus unter http://ir.cerus.com auf den Webcast und die Präsentationsfolien zugreifen. Es wird empfohlen, frühzeitig beizutreten (10 Minuten vorher), ist jedoch nicht zwingend erforderlich. Eine Aufzeichnung der Veranstaltung wird etwa drei Stunden nach dem Anruf bis zum 6. März 2025 auf der Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2024 financial results will be released on Thursday, February 20, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.

To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.

A replay will be available on Cerus’ website and will be available approximately three hours after the call through March 6, 2025.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Noopur Liffick

NBL LifeSci Advisory

925-298-2338

Source: Cerus Corporation

FAQ

When will Cerus (CERS) release Q4 and full-year 2024 earnings?

Cerus will release its Q4 and full-year 2024 financial results on Thursday, February 20, 2025, after the stock market closes.

What time is the CERS Q4 2024 earnings conference call?

The earnings conference call and webcast will be held at 4:30 P.M. ET on Thursday, February 20, 2025.

How can investors access the CERS Q4 2024 earnings webcast?

Investors can access the webcast through Cerus' Investor Relations webpage at http://ir.cerus.com.

Until when will the CERS Q4 2024 earnings call replay be available?

The earnings call replay will be available on Cerus' website until March 6, 2025.

Cerus

NASDAQ:CERS

CERS Rankings

CERS Latest News

CERS Stock Data

323.14M
176.84M
3.38%
78.03%
4.69%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CONCORD